Category: Press Release - Page 27 - Psychedelic Alpha

Read more about the article Transcend Therapeutics announces Series A funding round of $40 million

Transcend Therapeutics announces Series A funding round of $40 million

Post published:February 23, 2023
Post category:Press Release

Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Post published:February 22, 2023
Post category:Press Release

Read more about the article Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds

Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds

Post published:February 22, 2023
Post category:Press Release

Read more about the article Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor

Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor

Post published:February 21, 2023
Post category:Press Release

Read more about the article Numinus Expands Research Capabilities with new Phoenix Clinical Research Site

Numinus Expands Research Capabilities with new Phoenix Clinical Research Site

Post published:February 17, 2023
Post category:Press Release

Read more about the article Bright Minds Biosciences Announces Non-Executive Director Appointment

Bright Minds Biosciences Announces Non-Executive Director Appointment

Post published:February 17, 2023
Post category:Press Release

Read more about the article Pioneering Delix Therapeutics Study Published in ‘Science’ Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity

Pioneering Delix Therapeutics Study Published in ‘Science’ Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity

Post published:February 16, 2023
Post category:Press Release

Read more about the article Algernon NeuroScience Provides Update on Phase 1 DMT Clinical Study, Drug Found Safe to Proceed to Next Phase

Algernon NeuroScience Provides Update on Phase 1 DMT Clinical Study, Drug Found Safe to Proceed to Next Phase

Post published:February 16, 2023
Post category:Press Release

Read more about the article Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

Post published:February 16, 2023
Post category:Press Release

Read more about the article First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial with SPL028

First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial with SPL028

Post published:February 15, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.